Literature DB >> 19347271

Obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways.

Nomeli P Nunez1, Stephen D Hursting, Shoshana Yakar, Dan Fowler, Charles Vinson.   

Abstract

Current dogma suggests that the positive correlation between obesity and cancer is driven by white adipose tissue that accompanies obesity, possibly through excess secretion of adipokines. However, recent studies in fatless A-Zip/F-1 mice, which have undetectable adipokine levels but display accelerated tumor formation, suggest that adipokines are not required for the enhanced tumor development. The A-Zip/F-1 mice are also diabetic and display elevated circulating levels of other molecules frequently associated with obesity and carcinogenesis: insulin, insulin-like growth factor-1, and inflammatory cytokines. Therefore, we postulate that the pathways associated with insulin resistance and inflammation, rather than adipocyte-derived factors, may represent key prevention or therapeutic targets for disrupting the obesity-cancer link.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347271      PMCID: PMC5541853          DOI: 10.1007/978-1-60327-530-9_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

Review 1.  Obesity as a risk factor for development and poor prognosis of breast cancer.

Authors:  A R Carmichael
Journal:  BJOG       Date:  2006-08-31       Impact factor: 6.531

2.  Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis.

Authors:  S Chang; J R Alderfer; L Asmar; A U Buzdar
Journal:  Breast Cancer Res Treat       Date:  2000-11       Impact factor: 4.872

3.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

5.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

6.  Differences in expression, affinity, and function of soluble (s)IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses.

Authors:  Marat Khodoun; Christina C Lewis; Christina Lewis; Jun-Qi Yang; Tatyana Orekov; Crystal Potter; Thomas Wynn; Margaret Mentink-Kane; Gurjit K Khurana Hershey; Marsha Wills-Karp; Fred D Finkelman
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

7.  Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden).

Authors:  Annekatrin Lukanova; Stefan Söderberg; Pär Stattin; Richard Palmqvist; Eva Lundin; Carine Biessy; Sabina Rinaldi; Elio Riboli; Göran Hallmans; Rudolf Kaaks
Journal:  Cancer Causes Control       Date:  2002-08       Impact factor: 2.506

Review 8.  Insulin-like growth factors and cancer.

Authors:  Gregor Fürstenberger; Hans-Jörg Senn
Journal:  Lancet Oncol       Date:  2002-05       Impact factor: 41.316

9.  Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.

Authors:  Yiping Wu; Karen Cui; Keiko Miyoshi; Lothar Hennighausen; Jeffrey E Green; Jennifer Setser; Derek LeRoith; Shoshana Yakar
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

Review 10.  The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.

Authors:  B Afzali; G Lombardi; R I Lechler; G M Lord
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

View more
  8 in total

1.  Obesity promotes aerobic glycolysis in prostate cancer cells.

Authors:  David A Cavazos; Matthew J deGraffenried; Shruti A Apte; Laura W Bowers; Kaitlin A Whelan; Linda A deGraffenried
Journal:  Nutr Cancer       Date:  2014-09-29       Impact factor: 2.900

2.  Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.

Authors:  Manasi S Shah; David R Fogelman; Kanwal Pratap Singh Raghav; John V Heymach; Hai T Tran; Zhi-Qin Jiang; Scott Kopetz; Carrie R Daniel
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

Review 3.  Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?

Authors:  Jeff M P Holly; Li Zeng; Claire M Perks
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

4.  The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.

Authors:  Ruth E Patterson; Catherine R Marinac; Dorothy D Sears; Jacqueline Kerr; Sheri J Hartman; Lisa Cadmus-Bertram; Adriana Villaseñor; Shirley W Flatt; Suneeta Godbole; Hongying Li; Gail A Laughlin; Jesica Oratowski-Coleman; Barbara A Parker; Loki Natarajan
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

Review 5.  Obesity as an immune-modifying factor in cancer immunotherapy.

Authors:  Robert J Canter; Catherine T Le; Johanna M T Beerthuijzen; William J Murphy
Journal:  J Leukoc Biol       Date:  2018-05-15       Impact factor: 4.962

6.  Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.

Authors:  Y Nio; T Yamauchi; M Iwabu; M Okada-Iwabu; M Funata; M Yamaguchi; K Ueki; T Kadowaki
Journal:  Diabetologia       Date:  2012-09-16       Impact factor: 10.122

Review 7.  Metabolism and breast cancer risk: frontiers in research and practice.

Authors:  Ruth E Patterson; Cheryl L Rock; Jacqueline Kerr; Loki Natarajan; Simon J Marshall; Bilge Pakiz; Lisa A Cadmus-Bertram
Journal:  J Acad Nutr Diet       Date:  2012-11-03       Impact factor: 4.910

8.  Ethanolic Fraction of Terminalia tomentosa Attenuates Biochemical and Physiological Derangements in Diet Induced Obese Rat Model by Regulating Key Lipid Metabolizing Enzymes and Adipokines.

Authors:  Balaji Meriga; Parim Brahma Naidu; Ganjayi Muniswamy; Gen Hanuma Kumar; Ramavat Ravindar Naik; Suresh Pothani
Journal:  Pharmacogn Mag       Date:  2017-06-22       Impact factor: 1.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.